Uncategorized

The 3 Cannabis Trends That Will Ensure the Sector’s Meteoric Rise

by

After what was easily the hottest year for cannabis stocks, expectations on the legal marijuana related sector are higher than ever.

What remains to be of concern, is how this rapidly developing sector can maintain its growth into the future.

Of the dozen main players in the space, the average marijuana stock is up 332% over the past year.1

The overall optimism led researchers at New Frontier Data to project that the cannabis industry will have created a whopping 283,422 jobs, grow to and generate $2.3 Billion in tax revenue—both by 2020.2

The same study predicted that the sector as a whole will grow to $24.1 Billion by 2025.

But in order to maintain the course in order to get to $24 Billion, here are 3 Cannabis Trends That Will Ensure the Sector’s Meteoric Rise (and the example companies that go with them)

– Our first and favourite sector may surprise you because it is not actually the cultivation sector, it’s going to be way bigger, and we’ve found a company that is literally untouched as noted below in our first example –

  1.  BETTER TESTING AND EXTRACTION

    Company: Abattis Bioceuticals Corp (CSE: ATT – OTCQB: ATTBF)

    Mkt Cap: $15.21M

    Still very early in its company’s story, Abattis has wisely burst onto the scene as a tester.  Wasting no time in getting its cannabis testing facility opened in Langley, BC, ahead of Canada’s full-scale legalization4 of cannabis expected by July 1, 2018, Abattis swiftly got itself into the game and already has garnered revenues.

    Abattis Bioceuticals’ subsidiary Northern Vine Labs opened its doors in May 2017, to serve the rising demand for cannabis testing. The company had been pursuing that license since 2014, and officially became licensed in October 2016.

    What is cannabis testing?

    In order to maintain quality control, and meet both regulatory, and market demands, cannabis laboratories test for potency, purity, and details such as terpene counts. Testing also protects the consumer by screening for contaminants such as bacteria, heavy metals, and unapproved pesticides.

    (For more information on Health Canada’s mandatory testing on medical cannabis click here. )

    For the 52 licensed producers in Canada, Health Canada introduced random testing to address these issues. Abattis’s facility is just 1 of 30 approved facilities in Canada, and one of the eight in BC’s lower mainland. Even better, Abattis is the only company available on the public markets, making it a solid choice in this sector. Once recreational cannabis becomes available in mid-2018, everyone will have to use a facility like what Abattis already has a leg up on, so keep that in mind while the PPS is low here.

    So what exactly is the demand for cannabis testing like?

    The global cannabis testing market is expected to grow at a compound annual growth rate of 11.5%, culminating towards a $1.42 billion market by 2021.5

    In order to hit the shelves, producers will need to have an accurate depiction of the drug’s potency, including the levels of the most sought after medicinal components of cannabis, THC and CBD. To do that, even the mega producers will require a third party to test their product before it goes to market.

    Abattis is smartly staking itself as a leader in the testing field, having built a lab, and staffed it with industry experts to ensure the quality standard they promise the sector.

    The Northern Vine Labs facility will not just be used for testing, however. Another major component to the facility will be in extraction and formulation.

    This means that the company will be involved in innovation of methods to extract medicinal components from cannabis on a massive industrial scale, and to formulate them for consumer products.

    As a cooperative arm of the company to run in conjunction with Northern Vine Labs, Abattis has formed another subsidiary called Vergence, in order to market and sell natural, safe, and effective health products.

    Those products will target reducing pain caused from inflammation, boost immunity, and increase nutrient absorption. As natural remedies, these products will likely reach the market faster than a pharmaceutical product would, without the lengthy and costly clinical trials.

    According to the CBD Report published by The Hemp Business Journal, the US hemp-derived CBD market will total approximately $115 million this year, with an estimate to grow to $2.1 billion by 2020.6

    Abattis is tight-lipped about its ability to extract cannabinoids and terpenoids from cannabis at its facilities, however, it hasn’t been shy about hinting that it aims to be a leader in the extraction space. There’s a possibility that extraction will overtake testing as the company’s primary revenue model in the future.

     

  2.  MORE MEDICAL USES

    Company: Cara Therapeutics (CARA)

    Mkt Cap: $495M

    After a wild month that saw Cara Therapeutics rise to $26 per share, and plummeting to $12 per share within a week, this giant is on its way back to stardom.

    The bounce back came on the announcement of encouraging data from its phase 1 trials of oral CR845, as a treatment for pain and itching in patients with chronic kidney disease and undergoing hemodialysis. All tested doses were well tolerated when administrated daily.

    This came as a relief for shareholders after they saw the value of the company drop upon the same drug’s treatment for patients with osteoarthritis (OA) of the hip or knee. Lower doses achieved statistical significance. Only the highest dose received statistical significance. It’s still possible based on those results to test higher doses for significance.

    Medical marijuana sales, from pharmaceutical extracts to medically cultivated flowers, currently make up the lion’s share of the cannabis sector. Medical sales in 2017 are projected to grow to $5.3 billion in 2017, and account for 67% of total cannabis sales.2

    That means that medical cannabis patients are outspending adult-use consumers at a nearly 3 to 1 basis.

    While medical sales are projected to exceed $13.2 billion by 2020, the medical share of the total cannabis sales is expected to drop to 55% of all sales as well.

    Much of that has to do with the recreational legalization in larger states, like California, and in holiday states like Nevada.

    As cannabis stocks fly, the developers of new medicinal applications and products stand to make the most gains.

    While Cara fluctuated during its trials, new drug development was the reason that AXIM Biotechnologies (NASDAQ: AXIM) absolutely crushed it in 2016-17.

    As stated earlier, the average marijuana stock rose 332% over the last year.

    Much of that increase is skewed by the meteoric rise of AXIM Biotechnologies, whose year-over-year increase was 2,363%.

    You read that right.

    A large portion of that success can be attributed to the development of AXIM’s CanChew Plus Chewing Gum, used for the treatment of irritable bowel syndrome—or IBS. Used as an alternative delivery system to inhalation, CanChew tapped into the act of chewing which bypasses the gastrointestinal system and improves the bioavailability of cannabinoids.3

    Because medical uses for cannabis are still in their infancy, there are plenty of repeatable AXIM-like stories out there yet to be told.

 

  1. ENSURING A SUPPLY CHAIN SURPLUS

          Aurora Cannabis – ACBFF, ACB

          Mkt Cap: $941.6M

Second only to Axim over the last year was top performer Aurora Cannabis (NASDAQ:ACBFF)(TSX: ACB), which grew 465% year-over-year, rising from a low of $0.30 to $2.59 and a market cap just a shade under a Billion, at $941.6 million.

The company’s well deserved move to the TSX from the TSX venture this week is a pat on the back for a solid year that included record yields at Aurora’s Mountain View County production facility, and on the anticipation of the opening of its 100,000+ kg Aurora Sky facility to be located near the Edmonton International Airport.

With the nearing completion of a third production facility in Pointe-Claire, Quebec, Aurora’s production capacity is skyrocketing.

But supplies are still lagging in the market as a whole, especially after shelves emptied rapidly in Nevada after the state began adult-use sales on July 1.

Supply issues reached such dire levels, that Nevada Governor Brian Sandoval had to issue a state of emergency to allow state officials to decide on new rules to ease the shortage.7

As Canada (where Aurora is headquartered) inches closer to nation-wide marijuana legalization, it’s doubtful that the country will encounter the same scale of supply problems that hit Nevada.8 Especially with massive production coming from companies such as Aurora.

With other major Canadian producers, such as Canopy Growth Corp. (TSX: WEED) growing for both the North American and German markets, it’ll be interesting to see how supplies meet demand on a global scale.

GOING FORWARD

As a medicine, cannabis has still not been registered as a medicine in any country, and only a small number of cannabinoid medicines have reached the market.

With over 100 cannabinoids, and over 700 other compounds such as flavonoids and terpenes, the cannabis plant is still barely understood, as the legality over researching it, and testing its benefits has provided hurdles until recently.9

Public perception of the drug has changed significantly over the past decade, with it being seen more favourably than ever.

According to a survey2 done by New Frontier Data and Full Circle Research this January, 55% of respondents believed “cannabis should be legalized, regulated and taxed like cigarettes and alcohol”, and an additional 26% believed it should at least be “legal for medical use with a doctor’s recommendation.”

In fact, only 9% responded that cannabis should be illegal. Overall, 63% of those surveyed believed that the federal government should legalize cannabis, and 86% believed it has valid medical uses.

In 2016, 4 out of the 5 US states that voted on adult-use of cannabis passed legalization initiatives, with an average adult-use vote of 53% in favour. And all 4 states that voted on medical use passed their initiatives, with an average medical use vote of 62%.

For those that still hold doubt to the growth potential of the cannabis sector, there’s really nothing that will convince you. Sales are growing significantly for retailers, even as more retailers hit the scene.

In order to maintain this growth pattern, industry players will need to provide the market with More Medical Uses, Better Testing and Extraction, and to Ensure Supplies.

 

For American News Group

By G. Joel Chury

Edited by; American News Group Editorial Staff

 

FOOTNOTES:

1 – Motley Fool (July 2017) – The Average Marijuana Stock is up 332% over the past year

https://www.fool.com/investing/2017/07/24/the-average-marijuana-stock-is-up-332-over-the-tra.aspx?yptr=yahoo

2 – New Frontier Data – The Cannabis Industry Annual Report: 2017 Legal Marijuana Outlook

https://newfrontierdata.com/wp-content/uploads/2015/11/CIAR_Webinar_FINAL.pdf

3 – YAHOO! Finance – AXIM Biotech: Cannabinoid Potential Worth the Complexity

https://finance.yahoo.com/news/axim-biotech-cannabinoid-potential-worth-130000914.html

4 – Toronto Star – Trudeau government to legalize marijuana by Canada Day 2018: reports

https://www.thestar.com/news/canada/2017/03/26/trudeau-government-to-legalize-marijuana-by-canada-day-2018-reports.html

5 – Markets and Markets (March 2017) – Cannabis Testing Market by Product & Software (LC, GC, Spectroscopy (MS, Atomic), Column, Standards, Accessories, LIMS), Service (Potency, Pesticides, Heavy Metal, Genetic Testing), End User (Lab, Pharmaceutical, Research) – Global Forecast to 2021

https://www.marketsandmarkets.com/Market-Reports/cannabis-testing-market-46932450.html

6 – Hemp Business Journal – The CBD Report

https://www.hempbizjournal.com/the-cbd-report/

7 – Fox News (July 2017) – Nevada marijuana supply running low, state of emergency declared, governor says

https://www.foxnews.com/us/2017/07/11/nevada-marijuana-supply-running-low-state-emergency-declared-governor-says.html

8 – Fortune Magazine – Here’s Why Nevada’s Marijuana Supply Can’t Keep up with Sales

https://fortune.com/2017/07/12/nevada-marijuana-taxes-shortage/

9 – The Medicine Maker (June 2017) – Cannabis Complex

https://themedicinemaker.com/issues/0617/cannabis-complex/

Disclaimer: Nothing in this publication should be considered as personalized financial advice. We are not licensed under securities laws to address your particular financial situation. No communication by our employees to you should be deemed as personalized financial advice. Please consult a licensed financial advisor before making any investment decision. This is a paid advertisement and is neither an offer nor recommendation to buy or sell any security. We hold no investment licenses and are thus neither licensed nor qualified to provide investment advice. The content in this report or email is not provided to any individual with a view toward their individual circumstances. Americannewsgroup.com is a wholly-owned subsidiary of Market IQ Media Group, Inc. (“MIQ”). MIQ has been paid a fee for Abattis Bioceuticals Corp. from the company direct of ten thousand canadian dollars, as well as two hundred and fifty thousand free trading shares of ATT.CN for advertising and digital media. There may be 3rd parties who may have shares of Abattis Bioceuticals Corp., and may liquidate their shares which could have a negative effect on the price of the stock. This compensation constitutes a conflict of interest as to our ability to remain objective in our communication regarding the profiled company. Because of this conflict, individuals are strongly encouraged to not use this newsletter as the basis for any investment decision. We have no intentions of selling any shares within the next 72 hours of this publishing date (August 9, 2017), but reserve the right to buy and sell shares thereafter without any further notice.
While all information is believed to be reliable, it is not guaranteed by us to be accurate. Individuals should assume that all information contained in our newsletter is not trustworthy unless verified by their own independent research. Also, because events and circumstances frequently do not occur as expected, there will likely be differences between the any predictions and actual results. Always consult a real licensed investment professional before making any investment decision. Be extremely careful, investing in securities carries a high degree of risk; you may likely lose some or all of the investment

Here’s A Sector The Hedge Fund Managers Do Not Want You To Know About

by

Here’s why we are convinced that stocks like Sport Endurance, Inc. (OTC: SENZ) are on the cutting edge of a breakout market.

The numbers are impressive. More than two-thirds of American adults take dietary supplements each year, and according to a new economic impact report funded by the Council for Responsible Nutrition (CRN), the dietary supplement industry contributes $121.6 billion to the U.S. economy (about 0.68% of GDP). It also creates 754,645 jobs nationwide, and pays $38.4 billion in wages, not to mention generous taxes.

This particular sector has made more millionaires in the stock market than Mining and Technology combined, but yet, it remains relatively undetected on the average, everyday investors radar… Until now

Below you can find a comparison table that will show you the exact opportunities many big hedge fund managers have already cashed in on. It’s a little too late for us to see a serious Bull Run with those particular stocks, that’s why we have found the next one that could join this family and return some serious gains to your portfolio.

We’re focusing on SENZ in the sports nutrition and proactive segment, but before I get into all the details as to why this could be a serious game changer, I want to show you exactly what’s possible here with a company we’ve all heard of – Herbalife.

Before we offer our breakdown, we want to point out why SENZ is one of those stocks that is poised to move much higher and rated 72% BUY according to the indicators, yet still remains under the radar of most retail traders.

According to Barchart, a leading authority of technical analysis for monitoring and tracking stocks on line, SENZ is:

  • currently trading at around the $1.00 level
  • showing a 72% BUY rating calculated from 13 indicators
  • shows almost no resistance trading up to the $1.97 level
  • based on little resistance, the stock could trade up nearly 100% from its current price immediately on very little volume

Now, allow us to continue with a sector breakdown, and more very useful information on how to exploit what could be a massive portfolio win for all of us!

Herbalife is trading at roughly $72.50 / share so it would be hard to see any sort of huge percentage gains in the short term, but did show investors some quick, serious gains over the years

When we compare Sport Nutrition, Inc. (OTC: SENZ) with Herbalife, their business models are almost identical, the main difference is, timing. SENZ is growing at a rapid pace and is bargain priced at around $1.00 / share, so there’s plenty of upside, as early investors from this point will soon see.

When comparing Herbalife to Sport Nutrition, Inc. we noted how similar they are:

  • They sell nutritional supplements
  • The company continues to grow sales dramatically year-over-year
  • It uses a direct sales model

There is no denying it: this business model works and has created impressive profits for marketers, distributors and stakeholders in the company.

We’ve identified all the same qualities in SENZ, but it is still in the very early stages of development. For our readers, that means it is still affordable. Their stock is still sitting around $1 a share. How long that will last is questionable as they continue to roll out new products, but it is low-priced right now, which means the entry point is here and now if you want to take advantage of a growing company in this sector.

Investors Simply Can’t Believe Just How Profitable These Products Are

It’s no wonder that companies in this space attract a faithful following. The products that they sell are incredibly profitable. They don’t typically require FDA trials or lengthy development and many of them address legitimate health concerns… things like fatigue, depression, decreased libido or sex drive, joint stiffness, aging and other wellness issues.

If you want to make 200%, 600% or as much as 800% on a product, nutritional supplements is one of the few markets where you can guarantee those kinds of returns. Nutritional companies know this and are quick to respond to consumer demand.

SENZ Has the Right Mix Right from The Get Go

Sport Endurance, Inc. develops, markets, and distributes innovative nutritional supplement products throughout the United States. Their primary focus is on three areas of health that most directly impact the lives of most active adults – Total Wellness, Performance, and Recovery.

In the company’s words, “We believe improved health contributes to and promotes a higher quality of life. It’s our goal to improve health by providing quality and effective nutritional supplements.”

While that may sound like a simple mission, it is especially challenging, since these companies live or die by providing products that are big sellers. That’s where we think that SENZ has already got a huge head start.

Sport Endurance has strategically focused on some the biggest money making areas of the nutritional markets: wellness, performance and recovery.

Its initial offering in the Men’s Health category is the natural testosterone booster Ultra Peak T.

The product is designed to help men over thirty overcome decreasing testosterone levels. Low testosterone has been linked to decreased muscle tone, reduced energy levels, and even depression.

Ultra Peak T has a nutrient and ingredient profile supported by the science and endorsed by researchers. It’s considered an excellent supplement for men with low testosterone levels who are looking for an alternative to prescription drugs.

On the purely sports endurance side, SENZ has just released a breakthrough pre-workout drink under the brand name Sports Leg + Lung. The product is a pre-workout drink powder that is designed to boost performance for active adults across a number of athletic activities. Its primary ingredients include a proprietary blend of the patented and clinically-tested performance ingredient, Carnosyn® Beta-alanine, and L-Taurine.

Is it effective? According to the company’s studies, over 90% of the people experienced almost immediate benefits. That’s a big deal in the endurance business.

The products have received early rave reviews and are supported by industry experts who Sport Endurance relies on to endorse their products.

For example, Ultra Peak T is supported by Tavis Piattoly (MS, RD, LDN), who holds the distinction as the Sports Dietitian and Nutrition Consultant for the NFLPA Brain and Body Program at the Tulane Institute of Sports Medicine, Covington Orthopedic, and Fairchild Sports Performance and prior roles as Dietitian for the New Orleans Saints, New Orleans Pelicans, and Tulane University Athletics (2002-2016).

SENZ leverages its relationships with professionals in sports medicine and nutrition to get on top of the leading products.

Nutrition and Sports Nutrition Is Not A Bubble

It’s important not to look at this as a fad. It is not a bubble. The business is huge, extremely profitable and many public companies in the space are killing it.

It’s difficult to estimate the total value of the sports performance market, since there are a large number of crossover products, like infused sport beverages and foods. Let’s just say that it is already a very large piece of the $122 billion nutritional supplements pie – well into the billions.

The leading marketers have obviously caught on and are charging ahead with additives, beverages and supplements. These include Coke (Monster Energy), Pepsi (Gatorade) and Dr. Pepper, who are all on the leading front of this massive, multi-billion-dollar growth trend.

FEATURE STOCK: FOR COMPARISON

[table id=7 /]

The Winners: You Missed Out On These, But Still Good to Study

These stocks represent some of the stellar players in the nutrition and supplement market. There is a mix of large, medium and small cap stocks, but they demonstrate how successful this segment has been. They also show clearly just how prolific a company like Sport Endurance, Inc. could become using the right model.

[table id=5/]

Our Recommendation: We Give SENZ Our Strong BUY Rating

We see the opportunity for nutritional supplements and sports nutrition as a long and profitable road. There are many paths to go down from beverage enhancements to supplements and food additives. Any of these could be very successful given the right model, products and market strategy.

Our eyes are on the sports and endurance segments, along with the sports beverage market. These are potentially some of the biggest growth areas. Here’s why:

  • The population is taking greater responsibility for personal health
  • Peoples’ efforts are pointed towards wellness (being proactive through sport)
  • Even millennials are looking to better nutritional care for a longer, healthy life
  • Individuals are experiencing meaningful results gained from improved nutrition

.. all factors contributing to the massive health and sports nutrition markets where SENZ competes.

Who will be big winners?

Our money is on the innovators who attack the market… bring new ideas… take initiatives…use proven marketing models that have been time-tested by the leaders, like Herbalife and others.

That is the exact profile that we identified in SENZ that makes us give this company strong praise. They are focused, have great products and are supporting their efforts with innovative direct marketing using the latest approaches such as blogs, social media awareness and endorsements.

 

Nutritional Supplements are now contributing $122 billion to to the U.S. Economy. SENZ is diving headlong into the popular sports nutrition and wellness segment.

You Can’t Win the Game Unless You Are In The Game

Remember, you can sit on the sidelines and admire the big gains that the players in this market are enjoying, but to succeed you have to be in the game.

We are bullish on the sports nutrition segment of the nutritional and the supplement sector, but we like the entire business.

If SENZ were able to capture even one percent of the business that Herbalife is bringing through the door, it could be the most profitable healthcare or nutrition stock you will own this year, and for some time to come.

They appear to be moving very quickly on the right path.

USA News Group
Editorial Staff

 

 

 

Disclaimer: Nothing in this publication should be considered as personalized financial advice. We are not licensed under securities laws to address your particular financial situation. No communication by our employees to you should be deemed as personalized financial advice. Please consult a licensed financial advisor before making any investment decision. This is a paid advertisement and is neither an offer nor recommendation to buy or sell any security. We hold no investment licenses and are thus neither licensed nor qualified to provide investment advice. The content in this report or email is not provided to any individual with a view toward their individual circumstances. usanewsgroup.com is a wholly-owned subsidiary of Market IQ Media Group, Inc. (“MIQ”). MIQ has been paid a fee for Sport Endurance, Inc. advertising and digital media. There may be 3rd parties who may have shares of SENZ, and may liquidate their shares which could have a negative effect on the price of the stock. This compensation constitutes a conflict of interest as to our ability to remain objective in our communication regarding the profiled company. Because of this conflict, individuals are strongly encouraged to not use this newsletter as the basis for any investment decision. The owner/operator of USA News Group does not own any shares of SENZ.

While all information is believed to be reliable, it is not guaranteed by us to be accurate. Individuals should assume that all information contained in our newsletter is not trustworthy unless verified by their own independent research. Also, because events and circumstances frequently do not occur as expected, there will likely be differences between the any predictions and actual results. Always consult a real licensed investment professional before making any investment decision. Be extremely careful, investing in securities carries a high degree of risk; you may likely lose some or all of the investment

Here’s A Sector The Hedge Fund Managers Do Not Want You To Know About

by

Here’s why we are convinced that stocks like Sport Endurance, Inc. (OTC: SENZ) are on the cutting edge of a breakout market.

The numbers are impressive. More than two-thirds of American adults take dietary supplements each year, and according to a new economic impact report funded by the Council for Responsible Nutrition (CRN), the dietary supplement industry contributes $121.6 billion to the U.S. economy (about 0.68% of GDP). It also creates 754,645 jobs nationwide, and pays $38.4 billion in wages, not to mention generous taxes.

This particular sector has made more millionaires in the stock market than Mining and Technology combined, but yet, it remains relatively undetected on the average, everyday investors radar… Until now

Below you can find a comparison table that will show you the exact opportunities many big hedge fund managers have already cashed in on. It’s a little too late for us to see a serious Bull Run with those particular stocks, that’s why we have found the next one that could join this family and return some serious gains to your portfolio.

We’re focusing on SENZ in the sports nutrition and proactive segment, but before I get into all the details as to why this could be a serious game changer, I want to show you exactly what’s possible here with a company we’ve all heard of – Herbalife.

Before we offer our breakdown, we want to point out why SENZ is one of those stocks that is poised to move much higher and rated 72% BUY according to the indicators, yet still remains under the radar of most retail traders.

According to Barchart, a leading authority of technical analysis for monitoring and tracking stocks on line, SENZ is:

  • currently trading at around the $1.00 level
  • showing a 72% BUY rating calculated from 13 indicators
  • shows almost no resistance trading up to the $1.97 level
  • based on little resistance, the stock could trade up nearly 100% from its current price immediately on very little volume

Now, allow us to continue with a sector breakdown, and more very useful information on how to exploit what could be a massive portfolio win for all of us!

Herbalife is trading at roughly $72.50 / share so it would be hard to see any sort of huge percentage gains in the short term, but did show investors some quick, serious gains over the years

When we compare Sport Nutrition, Inc. (OTC: SENZ) with Herbalife, their business models are almost identical, the main difference is, timing. SENZ is growing at a rapid pace and is bargain priced at around $1.00 / share, so there’s plenty of upside, as early investors from this point will soon see.

When comparing Herbalife to Sport Nutrition, Inc. we noted how similar they are:

  • They sell nutritional supplements
  • The company continues to grow sales dramatically year-over-year
  • It uses a direct sales model

There is no denying it: this business model works and has created impressive profits for marketers, distributors and stakeholders in the company.

We’ve identified all the same qualities in SENZ, but it is still in the very early stages of development. For our readers, that means it is still affordable. Their stock is still sitting around $1 a share. How long that will last is questionable as they continue to roll out new products, but it is low-priced right now, which means the entry point is here and now if you want to take advantage of a growing company in this sector.

Investors Simply Can’t Believe Just How Profitable These Products Are

It’s no wonder that companies in this space attract a faithful following. The products that they sell are incredibly profitable. They don’t typically require FDA trials or lengthy development and many of them address legitimate health concerns… things like fatigue, depression, decreased libido or sex drive, joint stiffness, aging and other wellness issues.

If you want to make 200%, 600% or as much as 800% on a product, nutritional supplements is one of the few markets where you can guarantee those kinds of returns. Nutritional companies know this and are quick to respond to consumer demand.

SENZ Has the Right Mix Right from The Get Go

Sport Endurance, Inc. develops, markets, and distributes innovative nutritional supplement products throughout the United States. Their primary focus is on three areas of health that most directly impact the lives of most active adults – Total Wellness, Performance, and Recovery.

In the company’s words, “We believe improved health contributes to and promotes a higher quality of life. It’s our goal to improve health by providing quality and effective nutritional supplements.”

While that may sound like a simple mission, it is especially challenging, since these companies live or die by providing products that are big sellers. That’s where we think that SENZ has already got a huge head start.

Sport Endurance has strategically focused on some the biggest money making areas of the nutritional markets: wellness, performance and recovery.

Its initial offering in the Men’s Health category is the natural testosterone booster Ultra Peak T.

The product is designed to help men over thirty overcome decreasing testosterone levels. Low testosterone has been linked to decreased muscle tone, reduced energy levels, and even depression.

Ultra Peak T has a nutrient and ingredient profile supported by the science and endorsed by researchers. It’s considered an excellent supplement for men with low testosterone levels who are looking for an alternative to prescription drugs.

On the purely sports endurance side, SENZ has just released a breakthrough pre-workout drink under the brand name Sports Leg + Lung. The product is a pre-workout drink powder that is designed to boost performance for active adults across a number of athletic activities. Its primary ingredients include a proprietary blend of the patented and clinically-tested performance ingredient, Carnosyn® Beta-alanine, and L-Taurine.

Is it effective? According to the company’s studies, over 90% of the people experienced almost immediate benefits. That’s a big deal in the endurance business.

The products have received early rave reviews and are supported by industry experts who Sport Endurance relies on to endorse their products.

For example, Ultra Peak T is supported by Tavis Piattoly (MS, RD, LDN), who holds the distinction as the Sports Dietitian and Nutrition Consultant for the NFLPA Brain and Body Program at the Tulane Institute of Sports Medicine, Covington Orthopedic, and Fairchild Sports Performance and prior roles as Dietitian for the New Orleans Saints, New Orleans Pelicans, and Tulane University Athletics (2002-2016).

SENZ leverages its relationships with professionals in sports medicine and nutrition to get on top of the leading products.

Nutrition and Sports Nutrition Is Not A Bubble

It’s important not to look at this as a fad. It is not a bubble. The business is huge, extremely profitable and many public companies in the space are killing it.

It’s difficult to estimate the total value of the sports performance market, since there are a large number of crossover products, like infused sport beverages and foods. Let’s just say that it is already a very large piece of the $122 billion nutritional supplements pie – well into the billions.

The leading marketers have obviously caught on and are charging ahead with additives, beverages and supplements. These include Coke (Monster Energy), Pepsi (Gatorade) and Dr. Pepper, who are all on the leading front of this massive, multi-billion-dollar growth trend.

FEATURE STOCK: FOR COMPARISON

[table id=7 /]

The Winners: You Missed Out On These, But Still Good to Study

These stocks represent some of the stellar players in the nutrition and supplement market. There is a mix of large, medium and small cap stocks, but they demonstrate how successful this segment has been. They also show clearly just how prolific a company like Sport Endurance, Inc. could become using the right model.

[table id=5/]

Our Recommendation: We Give SENZ Our Strong BUY Rating

We see the opportunity for nutritional supplements and sports nutrition as a long and profitable road. There are many paths to go down from beverage enhancements to supplements and food additives. Any of these could be very successful given the right model, products and market strategy.

Our eyes are on the sports and endurance segments, along with the sports beverage market. These are potentially some of the biggest growth areas. Here’s why:

  • The population is taking greater responsibility for personal health
  • Peoples’ efforts are pointed towards wellness (being proactive through sport)
  • Even millennials are looking to better nutritional care for a longer, healthy life
  • Individuals are experiencing meaningful results gained from improved nutrition

.. all factors contributing to the massive health and sports nutrition markets where SENZ competes.

Who will be big winners?

Our money is on the innovators who attack the market… bring new ideas… take initiatives…use proven marketing models that have been time-tested by the leaders, like Herbalife and others.

That is the exact profile that we identified in SENZ that makes us give this company strong praise. They are focused, have great products and are supporting their efforts with innovative direct marketing using the latest approaches such as blogs, social media awareness and endorsements.

 

Nutritional Supplements are now contributing $122 billion to to the U.S. Economy. SENZ is diving headlong into the popular sports nutrition and wellness segment.

You Can’t Win the Game Unless You Are In The Game

Remember, you can sit on the sidelines and admire the big gains that the players in this market are enjoying, but to succeed you have to be in the game.

We are bullish on the sports nutrition segment of the nutritional and the supplement sector, but we like the entire business.

If SENZ were able to capture even one percent of the business that Herbalife is bringing through the door, it could be the most profitable healthcare or nutrition stock you will own this year, and for some time to come.

They appear to be moving very quickly on the right path.

USA News Group
Editorial Staff

 

 

 

Disclaimer: Nothing in this publication should be considered as personalized financial advice. We are not licensed under securities laws to address your particular financial situation. No communication by our employees to you should be deemed as personalized financial advice. Please consult a licensed financial advisor before making any investment decision. This is a paid advertisement and is neither an offer nor recommendation to buy or sell any security. We hold no investment licenses and are thus neither licensed nor qualified to provide investment advice. The content in this report or email is not provided to any individual with a view toward their individual circumstances. usanewsgroup.com is a wholly-owned subsidiary of Market IQ Media Group, Inc. (“MIQ”). MIQ has been paid a fee for Sport Endurance, Inc. advertising and digital media. There may be 3rd parties who may have shares of SENZ, and may liquidate their shares which could have a negative effect on the price of the stock. This compensation constitutes a conflict of interest as to our ability to remain objective in our communication regarding the profiled company. Because of this conflict, individuals are strongly encouraged to not use this newsletter as the basis for any investment decision. The owner/operator of USA News Group does not own any shares of SENZ.

While all information is believed to be reliable, it is not guaranteed by us to be accurate. Individuals should assume that all information contained in our newsletter is not trustworthy unless verified by their own independent research. Also, because events and circumstances frequently do not occur as expected, there will likely be differences between the any predictions and actual results. Always consult a real licensed investment professional before making any investment decision. Be extremely careful, investing in securities carries a high degree of risk; you may likely lose some or all of the investment

Here’s A Sector The Hedge Fund Managers Do Not Want You To Know About

by

Here’s why we are convinced that stocks like Sport Endurance, Inc. (OTC: SENZ) are on the cutting edge of a breakout market.

The numbers are impressive. More than two-thirds of American adults take dietary supplements each year, and according to a new economic impact report funded by the Council for Responsible Nutrition (CRN), the dietary supplement industry contributes $121.6 billion to the U.S. economy (about 0.68% of GDP). It also creates 754,645 jobs nationwide, and pays $38.4 billion in wages, not to mention generous taxes.

This particular sector has made more millionaires in the stock market than Mining and Technology combined, but yet, it remains relatively undetected on the average, everyday investors radar… Until now

Below you can find a comparison table that will show you the exact opportunities many big hedge fund managers have already cashed in on. It’s a little too late for us to see a serious Bull Run with those particular stocks, that’s why we have found the next one that could join this family and return some serious gains to your portfolio.

We’re focusing on SENZ in the sports nutrition and proactive segment, but before I get into all the details as to why this could be a serious game changer, I want to show you exactly what’s possible here with a company we’ve all heard of – Herbalife.

Before we offer our breakdown, we want to point out why SENZ is one of those stocks that is poised to move much higher and rated 72% BUY according to the indicators, yet still remains under the radar of most retail traders.

According to Barchart, a leading authority of technical analysis for monitoring and tracking stocks on line, SENZ is:

  • currently trading at around the $1.00 level
  • showing a 72% BUY rating calculated from 13 indicators
  • shows almost no resistance trading up to the $1.97 level
  • based on little resistance, the stock could trade up nearly 100% from its current price immediately on very little volume

Now, allow us to continue with a sector breakdown, and more very useful information on how to exploit what could be a massive portfolio win for all of us!

Herbalife is trading at roughly $72.50 / share so it would be hard to see any sort of huge percentage gains in the short term, but did show investors some quick, serious gains over the years

When we compare Sport Nutrition, Inc. (OTC: SENZ) with Herbalife, their business models are almost identical, the main difference is, timing. SENZ is growing at a rapid pace and is bargain priced at around $1.00 / share, so there’s plenty of upside, as early investors from this point will soon see.

When comparing Herbalife to Sport Nutrition, Inc. we noted how similar they are:

  • They sell nutritional supplements
  • The company continues to grow sales dramatically year-over-year
  • It uses a direct sales model

There is no denying it: this business model works and has created impressive profits for marketers, distributors and stakeholders in the company.

We’ve identified all the same qualities in SENZ, but it is still in the very early stages of development. For our readers, that means it is still affordable. Their stock is still sitting around $1 a share. How long that will last is questionable as they continue to roll out new products, but it is low-priced right now, which means the entry point is here and now if you want to take advantage of a growing company in this sector.

Investors Simply Can’t Believe Just How Profitable These Products Are

It’s no wonder that companies in this space attract a faithful following. The products that they sell are incredibly profitable. They don’t typically require FDA trials or lengthy development and many of them address legitimate health concerns… things like fatigue, depression, decreased libido or sex drive, joint stiffness, aging and other wellness issues.

If you want to make 200%, 600% or as much as 800% on a product, nutritional supplements is one of the few markets where you can guarantee those kinds of returns. Nutritional companies know this and are quick to respond to consumer demand.

SENZ Has the Right Mix Right from The Get Go

Sport Endurance, Inc. develops, markets, and distributes innovative nutritional supplement products throughout the United States. Their primary focus is on three areas of health that most directly impact the lives of most active adults – Total Wellness, Performance, and Recovery.

In the company’s words, “We believe improved health contributes to and promotes a higher quality of life. It’s our goal to improve health by providing quality and effective nutritional supplements.”

While that may sound like a simple mission, it is especially challenging, since these companies live or die by providing products that are big sellers. That’s where we think that SENZ has already got a huge head start.

Sport Endurance has strategically focused on some the biggest money making areas of the nutritional markets: wellness, performance and recovery.

Its initial offering in the Men’s Health category is the natural testosterone booster Ultra Peak T.

The product is designed to help men over thirty overcome decreasing testosterone levels. Low testosterone has been linked to decreased muscle tone, reduced energy levels, and even depression.

Ultra Peak T has a nutrient and ingredient profile supported by the science and endorsed by researchers. It’s considered an excellent supplement for men with low testosterone levels who are looking for an alternative to prescription drugs.

On the purely sports endurance side, SENZ has just released a breakthrough pre-workout drink under the brand name Sports Leg + Lung. The product is a pre-workout drink powder that is designed to boost performance for active adults across a number of athletic activities. Its primary ingredients include a proprietary blend of the patented and clinically-tested performance ingredient, Carnosyn® Beta-alanine, and L-Taurine.

Is it effective? According to the company’s studies, over 90% of the people experienced almost immediate benefits. That’s a big deal in the endurance business.

The products have received early rave reviews and are supported by industry experts who Sport Endurance relies on to endorse their products.

For example, Ultra Peak T is supported by Tavis Piattoly (MS, RD, LDN), who holds the distinction as the Sports Dietitian and Nutrition Consultant for the NFLPA Brain and Body Program at the Tulane Institute of Sports Medicine, Covington Orthopedic, and Fairchild Sports Performance and prior roles as Dietitian for the New Orleans Saints, New Orleans Pelicans, and Tulane University Athletics (2002-2016).

SENZ leverages its relationships with professionals in sports medicine and nutrition to get on top of the leading products.

Nutrition and Sports Nutrition Is Not A Bubble

It’s important not to look at this as a fad. It is not a bubble. The business is huge, extremely profitable and many public companies in the space are killing it.

It’s difficult to estimate the total value of the sports performance market, since there are a large number of crossover products, like infused sport beverages and foods. Let’s just say that it is already a very large piece of the $122 billion nutritional supplements pie – well into the billions.

The leading marketers have obviously caught on and are charging ahead with additives, beverages and supplements. These include Coke (Monster Energy), Pepsi (Gatorade) and Dr. Pepper, who are all on the leading front of this massive, multi-billion-dollar growth trend.

FEATURE STOCK: FOR COMPARISON

[table id=7 /]

The Winners: You Missed Out On These, But Still Good to Study

These stocks represent some of the stellar players in the nutrition and supplement market. There is a mix of large, medium and small cap stocks, but they demonstrate how successful this segment has been. They also show clearly just how prolific a company like Sport Endurance, Inc. could become using the right model.

[table id=5/]

Our Recommendation: We Give SENZ Our Strong BUY Rating

We see the opportunity for nutritional supplements and sports nutrition as a long and profitable road. There are many paths to go down from beverage enhancements to supplements and food additives. Any of these could be very successful given the right model, products and market strategy.

Our eyes are on the sports and endurance segments, along with the sports beverage market. These are potentially some of the biggest growth areas. Here’s why:

  • The population is taking greater responsibility for personal health
  • Peoples’ efforts are pointed towards wellness (being proactive through sport)
  • Even millennials are looking to better nutritional care for a longer, healthy life
  • Individuals are experiencing meaningful results gained from improved nutrition

.. all factors contributing to the massive health and sports nutrition markets where SENZ competes.

Who will be big winners?

Our money is on the innovators who attack the market… bring new ideas… take initiatives…use proven marketing models that have been time-tested by the leaders, like Herbalife and others.

That is the exact profile that we identified in SENZ that makes us give this company strong praise. They are focused, have great products and are supporting their efforts with innovative direct marketing using the latest approaches such as blogs, social media awareness and endorsements.

 

Nutritional Supplements are now contributing $122 billion to to the U.S. Economy. SENZ is diving headlong into the popular sports nutrition and wellness segment.

You Can’t Win the Game Unless You Are In The Game

Remember, you can sit on the sidelines and admire the big gains that the players in this market are enjoying, but to succeed you have to be in the game.

We are bullish on the sports nutrition segment of the nutritional and the supplement sector, but we like the entire business.

If SENZ were able to capture even one percent of the business that Herbalife is bringing through the door, it could be the most profitable healthcare or nutrition stock you will own this year, and for some time to come.

They appear to be moving very quickly on the right path.

USA News Group
Editorial Staff

 

 

 

Disclaimer: Nothing in this publication should be considered as personalized financial advice. We are not licensed under securities laws to address your particular financial situation. No communication by our employees to you should be deemed as personalized financial advice. Please consult a licensed financial advisor before making any investment decision. This is a paid advertisement and is neither an offer nor recommendation to buy or sell any security. We hold no investment licenses and are thus neither licensed nor qualified to provide investment advice. The content in this report or email is not provided to any individual with a view toward their individual circumstances. usanewsgroup.com is a wholly-owned subsidiary of Market IQ Media Group, Inc. (“MIQ”). MIQ has been paid a fee for Sport Endurance, Inc. advertising and digital media. There may be 3rd parties who may have shares of SENZ, and may liquidate their shares which could have a negative effect on the price of the stock. This compensation constitutes a conflict of interest as to our ability to remain objective in our communication regarding the profiled company. Because of this conflict, individuals are strongly encouraged to not use this newsletter as the basis for any investment decision. The owner/operator of USA News Group does not own any shares of SENZ.

While all information is believed to be reliable, it is not guaranteed by us to be accurate. Individuals should assume that all information contained in our newsletter is not trustworthy unless verified by their own independent research. Also, because events and circumstances frequently do not occur as expected, there will likely be differences between the any predictions and actual results. Always consult a real licensed investment professional before making any investment decision. Be extremely careful, investing in securities carries a high degree of risk; you may likely lose some or all of the investment

Canada ‘Firing on All Cylinders’ Before Rate Call, Morneau Says

by

The Canadian economy is firing on all cylinders and that means households have become more resilient to any new challenges, the country’s finance minister said.

Bill Morneau declined to weigh in on Bank of Canada Governor Stephen Poloz’s hotly anticipated rate decision on Wednesday, expected to be the first increase in seven years, but signaled a confidence in the growth underpinning calls to hike.

“I’m not going to talk about rates, it’s the Bank of Canada’s responsibility,” Morneau, the finance chief in Prime Minister Justin Trudeau’s government, said in a Bloomberg TV interview from the G-20 summit in Hamburg that aired Monday.

“What I do think is that, as the economy does better, that puts people in a better situation to face whatever the challenges — whether it’s a different economic environment, a personal situation or a change in global environment,” he said. “These are all things people are more resilient against when the economy is doing better.”

Canada added 45,300 jobs in June, the seventh consecutive monthly gain and four times as much as economists had predicted, according to data released Friday. Morneau cited that along with robust quarterly growth data as evidence of the economy’s strength, though risks such as a housing correction and persistently sluggish commodity prices continue to warrant caution.

“What we see back in Canada is that the global economies are positive, but the Canadian economy is really firing on all cylinders,” Morneau said.

Housing Concerns

The real-estate market is starting to level off, in part after measures from Morneau to tighten mortgage rules. The federal moves have so far “been positive,” he said, but housing remains “a risk for Canadian consumers that we know we need to manage.”

Morneau, who presented his second budget earlier this year, is now preparing a fall fiscal update that’s expected to include new policy measures. The strengthening economy is improving the government’s outlook, a potential political windfall for Morneau and Trudeau, who are running annual deficits of nearly C$30 billion ($23.3 billion). While modest globally — the debt-to-GDP ratio is stable — they are a potential electoral problem in a country that has been deficit-averse for a generation, and are three-times the scale the governing Liberal Party campaigned on.

The finance minister nonetheless signaled he won’t be changing tack.

“We’re actually in a very favorable position,” he said, adding that government measures so far are already driving job gains. “The fact our economy is growing and creating jobs, it’s very related to the economic policies we put in place. So we will move forward and continue with that approach.”

Read about which equities are set to shine with Poloz preparing to hike

Trudeau and Morneau have only recently begun to boast about Canada’s boom. One-time factors, like recovery from a major forest fire last year and the arrival of new government payments to lower-income families, could also be juicing the economy temporarily.

The finance minister said the most important thing for Canadians is that “when the economy goes well, they have more opportunities.” Asked about potential economic changes that arise from stronger growth, he said “you’ve got to take them in stride.”

Like to Cash In On the Nutritional Craze? Think Lifestyle Choices

by

Here’s why we are convinced that stocks like Sport Endurance, Inc. (OTC: SENZ) are on the cutting edge of a breakout market.

The numbers are impressive. More than two-thirds of American adults take dietary supplements each year, and according to a new economic impact report funded by the Council for Responsible Nutrition (CRN), the dietary supplement industry contributes $121.6 billion to the U.S. economy (about 0.68% of GDP). It also creates 754,645 jobs nationwide, and pays $38.4 billion in wages, not to mention generous taxes.

This particular sector has made more millionaires in the stock market than Mining and Technology combined, but yet, it remains relatively undetected on the average, everyday investors radar… Until now

Below you can find a comparison table that will show you the exact opportunities many big hedge fund managers have already cashed in on. It’s a little too late for us to see a serious Bull Run with those particular stocks, that’s why we have found the next one that could join this family and return some serious gains to your portfolio.

We’re focusing on SENZ in the sports nutrition and proactive segment, but before I get into all the details as to why this could be a serious game changer, I want to show you exactly what’s possible here with a company we’ve all heard of – Herbalife.

Herbalife is trading at roughly $72.50 / share so it would be hard to see any sort of huge percentage gains in the short term, but did show investors some quick, serious gains over the years

When we compare Sport Nutrition, Inc. (OTC: SENZ) with Herbalife, their business models are almost identical, the main difference is, timing. SENZ is growing at a rapid pace and is bargain priced at around $1.00 / share, so there’s plenty of upside, as early investors from this point will soon see.

When comparing Herbalife to Sport Nutrition, Inc. we noted how similar they are:

  • They sell nutritional supplements
  • The company continues to grow sales dramatically year-over-year
  • It uses a direct sales model

There is no denying it: this business model works and has created impressive profits for marketers, distributors and stakeholders in the company.

We’ve identified all the same qualities in SENZ, but it is still in the very early stages of development. For our readers, that means it is still affordable. Their stock is still sitting around $1 a share. How long that will last is questionable as they continue to roll out new products, but it is low-priced right now, which means the entry point is here and now if you want to take advantage of a growing company in this sector.

Investors Simply Can’t Believe Just How Profitable These Products Are

It’s no wonder that companies in this space attract a faithful following. The products that they sell are incredibly profitable. They don’t typically require FDA trials or lengthy development and many of them address legitimate health concerns… things like fatigue, depression, decreased libido or sex drive, joint stiffness, aging and other wellness issues.

If you want to make 200%, 600% or as much as 800% on a product, nutritional supplements is one of the few markets where you can guarantee those kinds of returns. Nutritional companies know this and are quick to respond to consumer demand.

SENZ Has the Right Mix Right from The Get Go

Sport Endurance, Inc. develops, markets, and distributes innovative nutritional supplement products throughout the United States. Their primary focus is on three areas of health that most directly impact the lives of most active adults – Total Wellness, Performance, and Recovery.

In the company’s words, “We believe improved health contributes to and promotes a higher quality of life. It’s our goal to improve health by providing quality and effective nutritional supplements.”

While that may sound like a simple mission, it is especially challenging, since these companies live or die by providing products that are big sellers. That’s where we think that SENZ has already got a huge head start.

Sport Endurance has strategically focused on some the biggest money making areas of the nutritional markets: wellness, performance and recovery.

Its initial offering in the Men’s Health category is the natural testosterone booster Ultra Peak T.

The product is designed to help men over thirty overcome decreasing testosterone levels. Low testosterone has been linked to decreased muscle tone, reduced energy levels, and even depression.

Ultra Peak T has a nutrient and ingredient profile supported by the science and endorsed by researchers. It’s considered an excellent supplement for men with low testosterone levels who are looking for an alternative to prescription drugs.

On the purely sports endurance side, SENZ has just released a breakthrough pre-workout drink under the brand name Sports Leg + Lung. The product is a pre-workout drink powder that is designed to boost performance for active adults across a number of athletic activities. Its primary ingredients include a proprietary blend of the patented and clinically-tested performance ingredient, Carnosyn® Beta-alanine, and L-Taurine.

Is it effective? According to the company’s studies, over 90% of the people experienced almost immediate benefits. That’s a big deal in the endurance business.

The products have received early rave reviews and are supported by industry experts who Sport Endurance relies on to endorse their products.

For example, Ultra Peak T is supported by Tavis Piattoly (MS, RD, LDN), who holds the distinction as the Sports Dietitian and Nutrition Consultant for the NFLPA Brain and Body Program at the Tulane Institute of Sports Medicine, Covington Orthopedic, and Fairchild Sports Performance and prior roles as Dietitian for the New Orleans Saints, New Orleans Pelicans, and Tulane University Athletics (2002-2016).

SENZ leverages its relationships with professionals in sports medicine and nutrition to get on top of the leading products.

Nutrition and Sports Nutrition Is Not A Bubble

It’s important not to look at this as a fad. It is not a bubble. The business is huge, extremely profitable and many public companies in the space are killing it.

It’s difficult to estimate the total value of the sports performance market, since there are a large number of crossover products, like infused sport beverages and foods. Let’s just say that it is already a very large piece of the $122 billion nutritional supplements pie – well into the billions.

The leading marketers have obviously caught on and are charging ahead with additives, beverages and supplements. These include Coke (Monster Energy), Pepsi (Gatorade) and Dr. Pepper, who are all on the leading front of this massive, multi-billion-dollar growth trend.

FEATURE STOCK: FOR COMPARISON

[table id=7 /]

The Winners: You Missed Out On These, But Still Good to Study

These stocks represent some of the stellar players in the nutrition and supplement market. There is a mix of large, medium and small cap stocks, but they demonstrate how successful this segment has been. They also show clearly just how prolific a company like Sport Endurance, Inc. could become using the right model.

[table id=5/]

Our Recommendation: We Give SENZ Our Strong BUY Rating

We see the opportunity for nutritional supplements and sports nutrition as a long and profitable road. There are many paths to go down from beverage enhancements to supplements and food additives. Any of these could be very successful given the right model, products and market strategy.

Our eyes are on the sports and endurance segments, along with the sports beverage market. These are potentially some of the biggest growth areas. Here’s why:

  • The population is taking greater responsibility for personal health
  • Peoples’ efforts are pointed towards wellness (being proactive through sport)
  • Even millennials are looking to better nutritional care for a longer, healthy life
  • Individuals are experiencing meaningful results gained from improved nutrition

.. all factors contributing to the massive health and sports nutrition markets where SENZ competes.

Who will be big winners?

Our money is on the innovators who attack the market… bring new ideas… take initiatives…use proven marketing models that have been time-tested by the leaders, like Herbalife and others.

That is the exact profile that we identified in SENZ that makes us give this company strong praise. They are focused, have great products and are supporting their efforts with innovative direct marketing using the latest approaches such as blogs, social media awareness and endorsements.

 

Nutritional Supplements are now contributing $122 billion to to the U.S. Economy. SENZ is diving headlong into the popular sports nutrition and wellness segment.

You Can’t Win the Game Unless You Are In The Game

Remember, you can sit on the sidelines and admire the big gains that the players in this market are enjoying, but to succeed you have to be in the game.

We are bullish on the sports nutrition segment of the nutritional and the supplement sector, but we like the entire business.

If SENZ were able to capture even one percent of the business that Herbalife is bringing through the door, it could be the most profitable healthcare or nutrition stock you will own this year, and for some time to come.

They appear to be moving very quickly on the right path.

USA News Group
Editorial Staff

 

 

 

Disclaimer: Nothing in this publication should be considered as personalized financial advice. We are not licensed under securities laws to address your particular financial situation. No communication by our employees to you should be deemed as personalized financial advice. Please consult a licensed financial advisor before making any investment decision. This is a paid advertisement and is neither an offer nor recommendation to buy or sell any security. We hold no investment licenses and are thus neither licensed nor qualified to provide investment advice. The content in this report or email is not provided to any individual with a view toward their individual circumstances. usanewsgroup.com is a wholly-owned subsidiary of Market IQ Media Group, Inc. (“MIQ”). MIQ has been paid a fee for Sport Endurance, Inc. advertising and digital media. There may be 3rd parties who may have shares of SENZ, and may liquidate their shares which could have a negative effect on the price of the stock. This compensation constitutes a conflict of interest as to our ability to remain objective in our communication regarding the profiled company. Because of this conflict, individuals are strongly encouraged to not use this newsletter as the basis for any investment decision. The owner/operator of USA News Group does not own any shares of SENZ.

While all information is believed to be reliable, it is not guaranteed by us to be accurate. Individuals should assume that all information contained in our newsletter is not trustworthy unless verified by their own independent research. Also, because events and circumstances frequently do not occur as expected, there will likely be differences between the any predictions and actual results. Always consult a real licensed investment professional before making any investment decision. Be extremely careful, investing in securities carries a high degree of risk; you may likely lose some or all of the investment